|
V.V. Fomin
Opening Remarks
|
|
|
V.V.Fomin, A.A. Svistunov
BETA-BLOCKERS AND HYPERTENSION: ARE THERE INSURMOUNTABLE LIMITS?
|
8-12 |
|
A.E. Karateev
KETOPROFEN: EFFECTIVE ANALGESIC WITH LOW RISK OF CARDIOVASCULAR COMPLICATIONS
|
13-23 |
|
V. N. Shishkova
OSTEOPOROSIS IN NEUROLOGICAL: PRACTICE: FOCUS ON THE SPINE
|
24-28 |
|
M. V. Putilina, M.A.Soldatov
SOME ASPECTS OF DRUG REHABILITATION OF ELDERLY PATIENTS AFTER STROKE
|
29-34 |
|
I.V.Zotova, D.A.Zateyshchikov
XA FACTOR INHIBITOR RIVAROXABAN IN ATRIAL FIBRILLATION
|
35-41 |
|
A.M. Shilov
ANTIHYPOXANTS AND ANTIOXIDANTS (ACTOVEGIN) IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR COMPLICATIONS
|
42-48 |
|
I.S. Preobrazhenskaya
POSTSTROKE COGNITIVE DISORDERS: CAUSES, CLINICAL PRESENTATIONS, AND TREATMENT
|
49-53 |
|
O.V. Kotova
SAFETY OF LONG-TERM USE OF NIMESULIDE (NISE)
|
54-58 |
|
A.L. Khokhlov, O.N. Kurochkina, A.A. Spassky
ANALYSIS OF THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME USING ATC/DDD METHODOLOGY
|
59-64 |
|
L.A. Strizhakov, S.V.Moiseev, E.N. Semenkova, E.A. Cogan, S.P. Pasha, E.I. Kuznetsova, V.E. Ditterle, N.A. Mukhin
CLINICAL PATHOMORPHOLOGICAL VERSIONS OF HEART DISEASE IN PATIENTS WITH SYSTEMIC VASCULITIS AND FEATURES OF NON-INVASIVE DIAGNOSTIC METHODS
|
65-71 |
|
E.A. Safronova
IMPACT OF NITROGLYCERIN ON PACEMAKER ACTIVITY OF THE SINUS NODE IN PATIENTS WITH ANGINA PECTORIS III - IV FUNCTIONAL CLASSES
|
72-76 |
|
V.I. Shmyrev, S.M. Kryzhanovsky
COMBINATION THERAPY OF ISCHEMIC STROKE USING CHOLINE ALFOSCERATE AND ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE
|
77-83 |
|
M.Yu. Maximova, T.N. Fedorova, T.N. Sharypova
THE USE OF MILDRONATE IN PATIENTS WITH CEREBROVASCULAR DISEASE
|
84-95 |
Русский
